Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Lexaria Bioscience Corp., US52886N3070

Lexaria Bioscience Corp., US52886N3070

01.09.2020 - 07:49:55

Lexaria Bioscience Corp.: Lexaria Bioscience announces R&D agreement with British American Tobacco

Phone: 866-221-3341

01.09.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Lexaria Bioscience Corp.

United States ISIN: US52886N3070 EQS News ID: 1125785 ? End of News DGAP News Service


@ dgap.de